Physician profile
Megan Murphy
NPI 1528081221
$947.56
in general payments reported to CMS, 2019-2025
15 companies · $437 in 2025
The $437 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $118 · 2022: $125 · 2023: $97.44 · 2024: $171 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $705.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $171.06 | 2025 | Carto 3 |
| Novo Nordisk INC | $125.00 | 2025 | Ozempic |
| Boston Scientific Corporation | $115.85 | 2021-2023 | |
| Scilex Pharmaceuticals INC. | $95.12 | 2023-2024 | Ztlido |
| Spr Therapeutics, INC | $75.73 | 2022-2024 | Sprint Pns System |
| Nevro Corp. | $64.01 | 2024 | Senza |
| Averitas Pharma INC. | $56.49 | 2023-2025 | Qutenza |
| Pfizer INC. | $47.47 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.14 | 2025 | Relistor |
| Globus Medical, INC. | $39.21 | 2025 | Senza |
| Baxter Healthcare | $36.41 | 2022 | |
| Ferring Pharmaceuticals INC. | $23.99 | 2024 | Rebyota |
| Nalu Medical, INC. | $20.34 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $19.93 | 2025 | |
| Medtronic, INC. | $12.81 | 2023 | Accurian |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.